Bottom-up sample preparation for the LC-MS/MS quantification of anti-cancer monoclonal antibodies in bio matrices
Therapeutic monoclonal antibodies (mAbs) are rapidly taking over the treatment of many malignancies, and an astonishing number of mAbs is in development. This causes a high demand for quantification of mAbs in biomatrices both for measuring therapeutic mAb concentrations and to support pharmacokinetics and pharmacodynamics studies.
Conventionally, ligand-binding assays are used for these purposes, but LC-MS is gaining popularity. Although intact (top-down) and subunit (middle-down) mAb quantification is reported, signature peptide (bottom-up) quantification is currently most advantageous.
This review provides an overview of the reported bottom-up mAb quantification methods in biomatrices as well as general recommendations regarding signature peptide and internal standard selection, reagent use and optimization of digestion in bottom-up quantification methods.
Description: A Mouse monoclonal antibody against Human Pepsinogen A (PGA). This antibody is labeled with PE.
×
Formulating monoclonalantibodies as powders for reconstitution at high concentration using spray-drying: Trehalose/amino acid combinations as reconstitution time reducing and stability improving formulations
To increase their stability, therapeutic (or monoclonal) antibodies (mAbs) are often formulated as solids by using a variety of drying techniques, e.g. freeze-drying, spray-drying, or spray freeze-drying. The addition of excipients is required to preserve stability of the protein during the drying process and subsequent storage of the resulting solid form.
The addition of low molecular weight excipients, such as amino acids, to sugar based spray- and freeze-dried formulations has been suggested to improve the storage stability of proteins in the dried state.
In this study sugars (sucrose, trehalose), amino acids (Gly, Ala, Pro, Ser, Val, Leu, Ile, Gln, His, Lys, Arg, Phe, Trp) and combinations thereof were investigated for their stabilizing effect during spray-drying and subsequent storage and for their reconstitution time reducing effect. Two IgG4 mAbs were used as model antibodies.
From an initial screening study, basic and small neutral amino acids, in combination with a sugar, such as sucrose or trehalose, showed reconstitution time reducing and stabilizing properties. Arg in particular displayed excellent reconstitution and stability enhancing properties. Moreover, Arg was the only amino acid providing stabilizing properties comparable to sucrose or trehalose.
Previous work by the authors described a statistically substantiated comparison between the three basic amino acids in a sugar containing formulation, albeit limited to a single concentration level [5]. Therefore, a follow-up design of experiments (DoE) study was performed to determine the optimum trehalose/amino acid content required for an optimal protein stability and reconstitution time and to compare the effects of two basic amino acids, Lys and Arg, to those of two neutral amino acids, Gly and Pro. The conducted DoE covered a wide range of trehalose (30 – 120 mM) and amino acid (50 – 150 mM)
The concentration of trehalose was found to be the main contributor to a reduction in reconstitution time and an increase in stability. Here we show that the addition of amino acids such as Gly, Pro, and Lys does not improve stability nor does it reduce the reconstitution time. Of the tested amino acids, only Arg showed a marked reduction in reconstitution time and improvement in stability compared to a trehalose.
Moreover, the properties displayed by Arg could justify its application as the main stabilizer in spray-dried mAb formulations, eliminating the need for a sugar matrix altogether. But the weight ratio of stabilizer to protein was found the factor exerting the strongest overall influence on the formulation’s reconstitution time and stability. More specifically, sufficient physical stability and an acceptable reconstitution time could be obtained with a protein to stabilizer weight ratio of at least 1:1.
Evaluation of two point of care technologies for measuring monoclonal antibody therapeutic-A concentrations in blood
Aim: Current blood monitoring methods require sample collection and testing at a central lab, which can take days. Point of care (POC) devices with quick turnaround time can provide an alternative with faster results, allowing for real-time data leading to better treatment decisions for patients.
Results/Methodology: An assay to measure monoclonal antibody therapeutic-A was developed on two POC devices. Data generated using 75 serum samples (65 clinical & ten spiked samples) show correlative results to the data generated using Gyrolab technology.
Conclusion: This case study uses a monoclonal antibody therapeutic-A concentration assay as an example to demonstrate the potential of POC technologies as a viable alternative to central lab testing with quick results allowing for real-time decision-making.
It is also known as a quantitative polymerase chain reaction. During the PCR it monitors the application of a targeted DNA. As it is a laboratory technique of molecular biology which is based on the polymerase chain reaction. Real-time PCR is used in two ways quantitatively i.e semi-quantitatively and if the amount of DNA Is below or above then it will be semi-quantitative real-time PCR.
It is the method that helps to determine the amount of PR product. A Quantitative polymerase chain reaction is also referred to as real-time PCR. Anyone who tried to perform quantization in the past days remembers experiments in which nucleic acid extracts were performed to arrive at a dilution that would be a range of the assay. This has lead to an unusual algorithm regarding the failure of controls for qualitative nucleic acid amplification testing.
q-lead
Methods of PCR
Non- specific fluorescent dyes.
It is a dye that intercalated with any of the double-stranded DNA.
Sequence-specific DNA probes
It is labeled with a fluorescent reporter, which allows the detection only after hybridization of the probe with its complementary sequence.Minimum information for publication of quantitative real-time PCR experiments (MIQE)
It is used for quantitative real-time PCR and it can also be used for reverse transcription and it commonly denotes reverse transcription-polymerase chain reaction and it is not real-time PCR.
Background.
An Expressed gene in a cell is a cell in which the number of cells can be measured by the number of an RNA transcript of that gene present in a sample. To detect and qualify gene in a small amount of RNA, amplification of gene transcript is necessary. It is a common method for amplifying DNA, and RNA samples firstly reverse transcribed to complementary DNA (cDNA) with reverse transcriptase.
to detect small amounts of DNA, the methodology used for conventional PCR using a DNA template is totally the same, a suitable buffer solution, at least one pair of specific primers, deoxyribonucleotides, and a thermo- stable DNA polymerase.
It also allows the rate of generation of the amplified product to be measured at each PCR CYCLE. To analyze the data that is generated by the computer software to calculate relative gene expression. To determine the presence of a particular DNA sequence quantitative PCR is applied. A Real-time method is a measurement that is made after each amplification cycle.
The modern methodologies for studying gene expression are Quantitative PCR and DNA microarray. some older methods that are used to measure mRNA abundance I.en Rnase protection assay, differential assay, and northern blot. Northern blotting is blotting that is used to visualize the abundance of its mRNA transcript in a sample. In this method, with a help of agarose gel electrophoresis RNA is separated and transferred to a solid matrix.
This technique is still used to assess gene expression which needs a large amount of RNA and also provides qualitative or semi-quantitative information of mRNA levels. It is developed for quantifying total gene expression, and it is most common are aimed at quantifying the specific gene being studied about to another gene is also known as the normalizing gene. These gene s also selected from housekeeping genes as their function is also related to basic cellular survival normally imply constitutive gene expression.
some normalizing genes that are commonly used are Cyclophilin, Tubulidentata, glyceraldehyde-3-phosphate dehydrogenase, and ribosomal RNAs.
Description: A Monoclonal antibody against Human PON1. The antibodies are raised in Mouse and are from clone 4G8D3. This antibody is applicable in WB and IHC, FC, ICC, E
Description: A Monoclonal antibody against Human PON1. The antibodies are raised in Mouse and are from clone 4G8A12. This antibody is applicable in WB and IHC, FC, E
Description: A Monoclonal antibody against Human Functional BAFF-R (mouse), mAb . The antibodies are raised in Purified From Concentrated Hybridoma Tissue Culture Supernatant. and are from clone 9B9. This antibody is applicable in FC